These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 6273857)

  • 1. Classification of multiple morphine and enkephalin binding sites in the central nervous system.
    Wolozin BL; Pasternak GW
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6181-5. PubMed ID: 6273857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL; Recht LD; Pasternak GW
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the binding characteristics of tritiated opiates and opioid peptides.
    Gillan MG; Kosterlitz HW; Paterson SJ
    Br J Pharmacol; 1980 Nov; 70(3):481-90. PubMed ID: 7437652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding and metabolism studies with [3H](D-Ala2,Leu5)enkephalinamide and [3H](D-Ala2,Pro5)enkephalinamide: evidence for a selective interaction of (D-Ala2,Pro5)enkephalinamide with mu-receptors.
    Audigier Y; Mazarguil H; Roy J; Morgat JL; Cros J
    Eur J Pharmacol; 1981 Sep; 74(4):273-8. PubMed ID: 6271558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of kappa- and sigma-opiates in rat brain.
    Wolozin BL; Nishimura S; Pasternak GW
    J Neurosci; 1982 Jun; 2(6):708-13. PubMed ID: 6283040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of rat brain opioid receptors by [Tyr-3,5-3H]1, D-Ala2, Leu5-enkephalin binding.
    Benyhe S; Tóth G; Kevei J; Szücs M; Borsodi A; Di Gléria K; Szécsi J; Süli-Vargha H; Medzihradszky K
    Neurochem Res; 1985 May; 10(5):627-35. PubMed ID: 2989719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The opiate receptor binding interactions of 3H-methionine enkephalin, an opioid peptide.
    Simantov R; Childers SR; Snyder SH
    Eur J Pharmacol; 1978 Feb; 47(3):319-31. PubMed ID: 204498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific protection of the binding sites of D-Ala2-D-Leu5-enkephalin (delta-receptors) and dihydromorphine (mu-receptors).
    Robson LE; Kosterlitz HW
    Proc R Soc Lond B Biol Sci; 1979 Aug; 205(1160):425-32. PubMed ID: 41257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of delta- but not mu-opiate agonist binding by calcium.
    Pfeiffer A; Herz A
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):147-53. PubMed ID: 6287305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metkephamid (Tyr-D-ala-Gly-Phe-N(Me)Met-NH2), a potent opioid peptide: receptor binding and analgesic properties.
    Burkhardt C; Frederickson RC; Pasternak GW
    Peptides; 1982; 3(5):869-71. PubMed ID: 6294639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxazone irreversibly inhibits the high affinity binding of [125I]D-ala2-D-leu5-enkephalin.
    Hazum E; Chang KJ; Cuatrecasas P; Pasternak GW
    Life Sci; 1981 Jun; 28(26):2973-9. PubMed ID: 6267402
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective protection of stereospecific enkephalin and opiate binding against inactivation by N-ethylmaleimide: evidence for two classes of opiate receptors.
    Smith JR; Simon EJ
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):281-4. PubMed ID: 6244551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible labelling of rat brain opioid receptors by enkephalin chloromethyl ketones.
    Benyhe S; Hepp J; Szucs M; Simon J; Borsodi A; Medzihradszky K; Wollemann M
    Neuropeptides; 1986; 8(2):173-81. PubMed ID: 3020473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of [3H]fentanyl binding to the opiate receptor.
    Villiger JW; Ray LJ; Taylor KM
    Neuropharmacology; 1983 Apr; 22(4):447-52. PubMed ID: 6304563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel opiate binding sites selective for benzomorphan drugs.
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4141-5. PubMed ID: 6270660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA; Lutz RA; Munson PJ; Rodbard D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia.
    Vaught JL; Rothman RB; Westfall TC
    Life Sci; 1982 Apr; 30(17):1443-55. PubMed ID: 6283293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.